Nord/LB set a €114.00 ($122.58) price objective on Merck KGaA (FRA:MRK) in a report released on Tuesday. The firm currently has a a buy rating on the stock.

Several other analysts have also commented on the stock. equinet AG set a €91.00 ($97.85) price objective on shares of Merck KGaA and gave the stock a neutral rating in a report on Tuesday. S&P Global Inc. set a €103.00 ($110.75) target price on shares of Merck KGaA and gave the company a neutral rating in a research note on Tuesday. Morgan Stanley set a €103.00 ($110.75) target price on shares of Merck KGaA and gave the company a neutral rating in a research note on Friday, November 11th. JPMorgan Chase & Co. set a €96.00 ($103.23) target price on shares of Merck KGaA and gave the company a neutral rating in a research note on Friday, November 11th. Finally, Commerzbank AG set a €101.00 ($108.60) target price on shares of Merck KGaA and gave the company a buy rating in a research note on Thursday, November 10th. One investment analyst has rated the stock with a sell rating, twelve have given a hold rating and ten have issued a buy rating to the company. The stock currently has a consensus rating of Hold and an average target price of €101.91 ($109.58).

Analyst Recommendations for Merck KGaA (FRA:MRK)

Merck KGaA (FRA:MRK) opened at 94.90 on Tuesday. Merck KGaA has a 1-year low of €70.87 and a 1-year high of €100.00. The stock has a market cap of €41.26 billion and a P/E ratio of 29.69. The company has a 50-day moving average price of €95.58 and a 200 day moving average price of €92.98.

Merck KGaA Company Profile

.

Receive News & Stock Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related stocks with our FREE daily email newsletter.